Parkinson's Disease

Author:

Echchakery Mohamed1,Guennouni Morad2ORCID,Amane Mounia3ORCID,Omari Mohammad4,El Baz Soraia5,Achbani Abderrahmane6,Draoui Ahmed7ORCID,Abdelmohcine Aimrane8,El Otmani Ihsane1,Rokni Taoufik9,Elmoumou Lahcen6,Hanchi Asmae Lamrani10

Affiliation:

1. Epidemiology and Biomedical Unit, Laboratory of Sciences and Health Technologies, Higher Institute of Health Sciences, Hassan First University, Settat, Morocco

2. Higher School of Education and Training, Chouaîb Doukkali University, El Jadida, Morocco

3. Faculty of Sciences SeFaculty of Sciences Semlalia, Cadi Ayyad University, Morocco

4. Laboratory of Biochemistry, Faculty of Law, Economic and Social Sciences, Hassan II University, Casablanca, Morocco

5. Laboratory BioMagE, Labeled Unit-CNRST N°4, FSSM,UCA, Morocco

6. Higher Institute of Nursing Professions and Health Techniques, Morocco

7. Faculty of Sciences Semlalia, Cadi Ayyad University, Morocco

8. Faculty of Sciences, University Chouaib Doukkali, Morocco

9. Independent Researcher, Morocco

10. Faculty of Medicine and Pharmacy of Marrakech, Morocco & Cadi Ayyad University, Morocco

Abstract

Parkinson's disease is a progressive neurodegenerative disease characterized by the deterioration and death of a type of brain cell (neurons) in the brain and the accumulation of protein clumps that are toxic to nerve cells. These cells produce the molecule dopamine, involved in the coordination and generation of muscle movements. It affects millions of people around the world and causes permanent damage. It is a progressive disease in which the symptoms can degenerate. Thanks to the progress made in recent years, the pathophysiological processes at work are better understood. Ultimately, these discoveries should lead to the development of treatments capable of stopping or slowing the progression of the disease. But for the time being, the management of patients is mainly based on the administration of dopamine, in order to compensate for the effects linked to neurodegeneration and those of other drugs, which make it possible to relieve the non-motor symptoms of the disease.

Publisher

IGI Global

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3